SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma

American Journal of Surgical Pathology

Volumn 34, Issue 4, 2010, Pages 533-540

  Ushiku, Tetsuo ^a   Shinozaki, Aya ^a   Shibahara, Junji ^a   Iwasaki, Yoshiaki ^b   Tateishi, Yoko ^c   Funata, Nobuaki ^c   Fukayama, Masashi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Second Department of Surgery   (Japan)

^c TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

Author keywords

A fetoprotein; Gastric carcinoma; Glypican 3; SALL4

Indexed keywords

ALPHA FETOPROTEIN; GLYPICAN; SALL4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; CANCER STAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; FETUS; GESTATIONAL AGE; HEPATOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAHEPATIC BILE DUCT; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PRENATAL DEVELOPMENT; STOMACH; STOMACH TUMOR; TISSUE MICROARRAY;

ADENOCARCINOMA; AGED; ALPHA-FETOPROTEINS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FETUS; GESTATIONAL AGE; GLYPICANS; HEPATOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; STOMACH; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950196211     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181d1dcdd     Document Type: Article

References (37)

1. Akiyama S, Tamura G, Endoh Y, et al. Histogenesis of hepatoid adenocarcinoma of the stomach: molecular evidence of identical origin with coexistent tubular adenocarcinoma. Int J Cancer. 2003; 106:510-515.
2. Cao D, Guo S, Allan RW, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009;33:894-904.
3. Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer. 2009;115: 2640-2651.
4. Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009;33:1065-1077.
5. Chang YC, Nagasue N, Abe S, et al. Alpha fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut. 1991;32:542-545.
6. Chang YC, Nagasue N, Abe S, et al. Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol. 1992;87:321-325.
7. Eom BW, Jung SY, Yoon H, et al. Gastric choriocarcinoma admixed with an alpha-fetoprotein-producing adenocarcinoma and separated adenocarcinoma. World J Gastroenterol. 2009;15:5106-5108.
8. Garcia RL, Ghali VS. Gastric choriocarcinoma and yolk sac tumor in a man: observations about its possible origin. Hum Pathol. 1985;16:955-958.
9. Gitlin D, Perricelli A, Gitlin GM. Synthesis of a-fetoprotein by liver, yolk sac, and gastrointestinal tract of the human conceptus. Cancer Res. 1972;32:979-982.
10. Hippo Y, Watanabe K, Watanabe A, et al. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res. 2004;64: 2418-2423.
11. Hishinuma M, Ohashi KI, Yamauchi N, et al. Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma. Histopathology. 2006;49:479-486.
12. Ishiguro T, Sugimoto M, Kinoshita Y, et al. Anti-glypican 3 antibody as a potential antitumor agent for human liver cancer. Cancer Res. 2008;68:9832-9838.
13. Ishikura H, Kirimoto K, Shamoto M, et al. Hepatoid adenocarci-nomas of the stomach. An analysis of seven cases. Cancer. 1986;58: 119-126.
14. Kim MA, Lee HS, Yang HK, et al. Cytokeratin expression profile in gastric carcinomas. Hum Pathol. 2004;35:576-581.
15. Kodama T, Kameya T, Hirota T, et al. Production of alpha-fetoprotein, normal serum proteins, and human chorionic gonado-tropin in stomach cancer: histologic and immunohistochemical analyses of 35 cases. Cancer. 1981;48:1647-1655.
16. Kono K, Amemiya H, Sekikawa T, et al. Clinicopathologic features of gastric cancers producing alpha-fetoprotein. Dig Surg. 2002;19: 359-365; discussion 365.
17. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965; 64:31-49.
18. Li M, Choo B, Wong ZM, et al. Expression of OCI-5/glypican 3 during intestinal morphogenesis: regulation by cell shape in intestinal epithelial cells. Exp Cell Res. 1997;235:3-12.
19. Maeda T, Kajiyama K, Adachi E, et al. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod Pathol. 1996;9:901-909.
20. Maehara Y, Sakaguchi Y, Moriguchi S, et al. Signet ring cell carcinoma of the stomach. Cancer. 1992;69:1645-1650.
21. Matsunou H, Konishi F, Jalal RE, et al. Alpha-fetoprotein-producing gastric carcinoma with enteroblastic differentiation. Cancer. 1994;73:534-540.
22. Mei K, Liu A, Allan RW, et al. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Mod Pathol. 2009;22:1628-1636.
23. Motomura Y, Ikuta Y, Kuronuma T, et al. HLA-A2 and A24-restricted glypican-3-derived peptide vaccine induces specific CTLs: preclinical study using mice. Int J Oncol. 2008;32:985-990.
24. Motoyama T, Aizawa K, Watanabe H, et al. alpha-Fetoprotein producing gastric carcinomas: a comparative study of three different subtypes. Acta Pathol Jpn. 1993;43:654-661.
25. Motoyama T, Aizawa K, Fujiwara T, et al. Coexistence of chorio-carcinoma and hepatoid adenocarcinoma in the stomach. Pathol Int. 1994;44:716-721.
26. Nagai E, Ueyama T, Yao T, et al. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis. Cancer. 1993;72:1827-1835.
27. Ooi A, Okada Y, Minamoto T, et al. A case of alpha-fetoprotein-producing gastric carcinoma with histologic features of embryonal carcinoma (in Japanese). Gan No Rinsho. 1985;31:334-340.
28. Ooi A, Nakanishi I, Sakamoto N, et al. Alpha-fetoprotein (AFP)-producing gastric carcinoma. Is it hepatoid differentiation? Cancer. 1990;65:1741-1747.
29. Sentani K, Oue N, Sakamoto N, et al. Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach. Mod Pathol. 2008;21: 464-475.
30. Terracciano LM, Glatz K, Mhawech P, et al. Hepatoid adenocarci-noma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases. Am J Surg Pathol. 2003;27:1302-1312.
31. Ushiku T, Uozaki H, Shinozaki A, et al. Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas. Cancer Sci. 2009;100:626-632.
32. Wang F, Liu A, Peng Y, et al. Diagnostic Utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol. 2009. [Epub ahead of print].
33. Wang J, Rao S, Chu J, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature. 2006;444:364-368.
34. Wu Q, Chen X, Zhang J, et al. Sall4 interacts with Nanog and co-occupies Nanog genomic sites in embryonic stem cells. J Biol Chem. 2006;281:24090-24094.
35. Yamauchi N, Watanabe A, Hishinuma M, et al. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocel-lular carcinoma. Mod Pathol. 2005;18:1591-1598.
36. Yang J, Chai L, Fowles TC, et al. Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells. Proc Natl Acad Sci USA. 2008;105:19756-19761.
37. Zhang J, Tam WL, Tong GQ, et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the tran-scriptional regulation of Pou5f1. Nat Cell Biol. 2006;8:1114-1123.